지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수1
I. Chapter 1. General Introduction 11. Inflammatory bowel disease (IBD) and probiotics. 12. Beneficial effects of probiotics 43. Dextran sodium sulfate (DSS)-induced colitis in mice 5II. Chapter 2. Effects of Bifidobacterium animalis subsp. lactis strain BB12 on Dextran Sodium Sulfate-Induced Colitis in Mice 101. Materials and Methods 10i. Animal study 10ii. Evaluation of colitis 11iii. Histopathological analysis 11iv. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining 11v. Immunofluorescence 12vi. Immunoblot analysis. 13vii. Statistical analysis 142. Results and Discussion 16i. Protective effects of BB-12 on DSS-induced colitis 16ii. Effects of BB-12 on DSS-induced IEC apoptosis 19iii. Effects of BB-12 on TNF-α-induced cell death in IECs 22III. Chapter 3. LB-9, Novel Probiotic Lactic Acid Bacteria, Ameliorates Dextran Sodium Sulfate-Induced Colitis in Mice by Inhibiting TNFα-Mediated Apoptosis of Intestinal Epithelial Cells. 261. Materials and Methods 26i. Animal study 26ii. Evaluation of colitis 27iii. Histopathological analysis 27iv. TUNEL staining 27v. Immunofluorescence 28vi. Immunoblot analysis 28vii. Statistical analysis 292. Results and Discussion 31i. LB-9 has a protective effect against DSS-induced colitis. 31ii. LB-9 treatment protects against DSS-induced IEC apoptosis 34iii. LB-9 treatment reduces TNF-α-induced cell death in IECs 37IV. Conclusion 41V. References 42VI. Abstract (Korean). 47
0